Osteocyte RANKL: New insights into the control of bone remodeling

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jbmr.1547PMID 22354849PMCID PMC3449092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

  2011cited by this paper
• Matrix-embedded cells control osteoclast formation

  2011influential reference
• Evidence for osteocyte regulation of bone homeostasis through RANKL expression

  2011influential reference
• Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro

  2011cited by this paper
• The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.

  2010cited by this paper
• Continuous Elevation of PTH Increases the Number of Osteoblasts via Both Osteoclast-Dependent and -Independent Mechanisms

  2010cited by this paper
• Osteocyte apoptosis and control of bone resorption following ovariectomy in mice.

  2010cited by this paper
• The Amazing Osteocyte

  2010cited by this paper
• Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression*

  2009cited by this paper
• Osteocyte Apoptosis Controls Activation of Intracortical Resorption in Response to Bone Fatigue

  2009cited by this paper
• Genetic control of bone formation.

  2009cited by this paper
• Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.

  2009influential reference
• Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.

  2009influential reference
• Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass.

  2008cited by this paper
• Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.

  2008cited by this paper
• Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes

  2008cited by this paper
• Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin*

  2008cited by this paper
• Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts

  2007cited by this paper
• DMP1-targeted Cre Expression in Odontoblasts and Osteocytes

  2007cited by this paper
• Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

  2007cited by this paper
• Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.

  2007cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• Role of osteoblasts in hormonal control of bone resorption—A hypothesis

  2006cited by this paper
• Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors

  2006cited by this paper
• Bone Marrow Cell Differentiation Induced by Mechanically Damaged Osteocytes in 3D Gel‐Embedded Culture

  2006cited by this paper
• Concerted Action of Smad and CREB-binding Protein Regulates Bone Morphogenetic Protein-2-stimulated Osteoblastic Colony-stimulating Factor-1 Expression*

  2006cited by this paper
• Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss

  2006influential reference
• Remodeling and Vascular Spaces in Bone

  2006cited by this paper
• Parathyroid Hormone Controls Receptor Activator of NF-κB Ligand Gene Expression via a Distant Transcriptional Enhancer

  2006cited by this paper
• Biomechanical and molecular regulation of bone remodeling.

  2006cited by this paper
• Heterogeneity of engrafted bone-lining cells after systemic and local transplantation.

  2005cited by this paper
• Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

  2005cited by this paper
• Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat

  2005cited by this paper
• Dentin Matrix Protein 1 Gene Cis-regulation

  2005cited by this paper
• Dentin Matrix Protein 1 Gene Cis-regulation USE IN OSTEOCYTES TO CHARACTERIZE LOCAL RESPONSES TO MECHANICAL LOADING IN VITRO AND IN VIVO*

  2005cited by this paper
• Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.

  2004cited by this paper
• Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene.

  2004cited by this paper
• Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist

  2004cited by this paper
• Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

  2003cited by this paper
• Treatment of Myoblastic C2C12 Cells with BMP-2 Stimulates Vitamin D-induced Formation of Osteoclasts

  2003cited by this paper
• In vivo administration of 1,25‐dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH

  2003cited by this paper
• Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass*

  2003cited by this paper
• PTH Differentially Regulates Expression of RANKL and OPG

  2003cited by this paper
• RANKL Expression Is Related to the Differentiation State of Human Osteoblasts

  2003cited by this paper
• Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

  2003cited by this paper
• Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

  2002cited by this paper
• MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation

  2002influential reference
• Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression.

  2002cited by this paper
• Parathyroid Hormone Stimulates Receptor Activator of NFκB Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein*

  2002cited by this paper
• Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization*

  2002cited by this paper
• A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

  2002cited by this paper
• Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

  2002cited by this paper
• Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer

  2002cited by this paper
• Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.

  2001cited by this paper
• Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts.

  2001cited by this paper
• Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity.

  2001cited by this paper
• Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

  2001cited by this paper
• Expression Profiles of Receptor Activator of Nuclear Factor κB Ligand, Receptor Activator of Nuclear Factor κB, and Osteoprotegerin Messenger RNA in Aged and Ovariectomized Rat Bones

  2001cited by this paper
• Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

  2001cited by this paper
• A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy.

  2001cited by this paper
• Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

  2000cited by this paper
• The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.

  2000cited by this paper
• Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo

  2000cited by this paper
• Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• The Role of Estrogen in the Control of Rat Osteocyte Apoptosis

  1998cited by this paper
• Dissociation between bone resorption and bone formation in osteopenic transgenic mice.

  1998cited by this paper
• The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone.

  1997cited by this paper
• Inducible cyclo‐oxygenase (COX‐2) mediates the induction of bone formation by mechanical loading in vivo

  1996cited by this paper
• Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone

  1994cited by this paper
• The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

  1990cited by this paper
• The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

  1989cited by this paper
• Osteoblastic cells are involved in osteoclast formation.

  1988cited by this paper
• The FASEB Journal express article 10.1096/fj.05-4221fje. Published online August 25, 2005. ©2005 FASEB

  year unknowncited by this paper

• Engineering a Wnt-activated osteomimetic microenvironment with iPSC-derived MSCs for synergistic bone regeneration, angiogenesis, and neurogenesis.

  2026cites this paper
• Osteoporosis in Patients with Pre-Existing Diabetes Mellitus and in Women with Estrogen Deficiency: A Molecular and Cellular Perspective

  2026cites this paper
• Lipocalin-2 upregulation in hypoxic murine osteocytes enhances RANKL-induced osteoclastogenesis

  2026cites this paper
• Adverse Outcome Pathways Applied to Space Radiation Research

  2025cites this paper
• Role of SOST in Response to Mechanical Stimulation in Bone and Extraosseous Organs

  2025cites this paper
• TWEAK and Fn14 expression in osteoarthritis: evidence for TWEAK-induced RANKL release from chondrocytes

  2025cites this paper
• Epigenetic modifications in Bone metabolism: Exploring the link with osteoporosis

  2025cites this paper
• Osteocyte dysregulation in periodontitis: Pathological mechanisms and therapeutic potential.

  2025cites this paper
• Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes

  2025cites this paper
• Bone Marrow Adipoq-lineage Progenitors: an Emerging Osteoclast Niche Cell Population

  2025cites this paper
• Effects of aerobic treadmill exercise on the bone turnover in obese male mice

  2025cites this paper
• Brain–Bone Axis in Physiological and Pathological Conditions

  2025cites this paper
• AOP Report: Development of an adverse outcome pathway for deposition of energy leading to bone loss

  2024cites this paper
• Bone-on-a-chip simulating bone metastasis in osteoporosis

  2024cites this paper
• Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers

  2024cites this paper
• Osteoporosis treatments for intervertebral disc degeneration and back pain: a perspective

  2024cites this paper
• Deletion of FNDC5/irisin modifies murine osteocyte function in a sex-specific manner

  2024cites this paper
• Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway.

  2024cites this paper
• Receptors Implicated in Microgravity-Induced Bone Loss

  2024cites this paper
• Genome-Wide Scans for Selection Signatures in Ningxia Angus Cattle Reveal Genetic Variants Associated with Economic and Adaptive Traits

  2024cites this paper
• Molecular mechanism of bone metastasis in breast cancer.

  2024cites this paper
• Mechanical Unloading Promotes Osteoclastic Differentiation and Bone Resorption by Modulating the MSC Secretome to Favor Inflammation

  2024cites this paper
• A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease

  2024cites this paper
• P2Y2 Inhibition Modifies the Anabolic Response to Exercise in Adult Mice

  2024cites this paper
• The Impact of Non-bone Metastatic Cancer on Musculoskeletal Health

  2024cites this paper
• Genetic interactions between polycystin-1 and Wwtr1 in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice

  2023cites this paper
• The multiple roles of salt-inducible kinases in regulating physiology

  2023cites this paper
• Engineering Antioxidant Surfaces for Titanium-Based Metallic Biomaterials

  2023cites this paper
• Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview

  2023cites this paper
• Deletion of FNDC5/Irisin modifies murine osteocyte function in a sex-specific manner

  2023cites this paper
• Genetic interactions between Polycystin-1 and TAZ in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice

  2023cites this paper
• Inflammatory Processes Affecting Bone Health and Repair

  2023cites this paper
• Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling.

  2023cites this paper
• Identification of an intronic enhancer regulating RANKL expression in osteocytic cells

  2023cites this paper
• The effect of osteocyte-derived RANKL on bone graft remodeling: An in vivo experimental study.

  2023cites this paper
• Fluoxetine treatment during the postpartal period may have short-term impacts on murine maternal skeletal physiology

  2023cites this paper
• Early protection against bone stress injuries by mobilization of endogenous targeted bone remodeling

  2023cites this paper
• Effective investigation of murine femoral bone development utilizing correlative light and electron microscopy (CLEM)

  2023cites this paper
• Metabolic Health and Disease: A Role of Osteokines?

  2023cites this paper
• Osteoimmunology of Spondyloarthritis

  2023cites this paper
• Towards Polycaprolactone-Based Scaffolds for Alveolar Bone Tissue Engineering: A Biomimetic Approach in a 3D Printing Technique

  2023cites this paper
• Role of the Osteocyte in Musculoskeletal Disease

  2023cites this paper
• The dynamic microenvironment associated with metastatic bone disease: Current concepts.

  2023cites this paper
• RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model

  2022cites this paper
• Inhibition of Neddylation Suppresses Osteoclast Differentiation and Function In Vitro and Alleviates Osteoporosis In Vivo

  2022cites this paper
• Bone resorption in periodontal disease: the role of RANK, RANKL and OPG. A literature review

  2022cites this paper
• Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling

  2022cites this paper
• Biomaterial-induced pathway modulation for bone regeneration.

  2022cites this paper
• Aluminum intake in the neonatal phase disrupts endochondral ossification in rodents.

  2022cites this paper
• IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection

  2022cites this paper
• Induction of a NOTCH3 Lehman syndrome mutation in osteocytes causes osteopenia in male C57BL/6J mice.

  2022cites this paper
• Pregnancy, Lactation, and Bone Health

  2022cites this paper
• RANKL and RANK in extracellular vesicles: surprising new players in bone remodeling

  2021cites this paper
• The role of osteocytes-specific molecular mechanism in regulation of mechanotransduction – A systematic review

  2021cites this paper
• The Skeleton of Lateral Meningocele Syndrome

  2021cites this paper
• Effects of competitive physical activity on serum irisin levels and bone turnover markers

  2021cites this paper
• Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling

  2021cites this paper
• Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage

  2021cites this paper
• Immobilization osteoporosis

  2021cites this paper
• Impact of MGUS and myeloma on skeletal health

  2021cites this paper
• Altered canalicular remodeling associated with femur fracture in mice

  2021cites this paper
• Nuts and bolts of the salt-inducible kinases (SIKs)

  2021cites this paper
• Effects of Digestive Diseases on Bone Metabolism

  2021cites this paper
• Endocrine Regulation of Extra-skeletal Organs by Bone-derived Secreted Protein and the effect of Mechanical Stimulation

  2021cites this paper
• A Human Osteocyte Cell Line Model for Studying Staphylococcus aureus Persistence in Osteomyelitis

  2021cites this paper
• Effect of type 2 diabetes on bone cell behavior

  2021cites this paper
• Plasma Membrane Receptors Involved in the Binding and Response of Osteoclasts to Noncellular Components of the Bone

  2021cites this paper
• The Skeletal Cellular and Molecular Underpinning of the Murine Hindlimb Unloading Model

  2021cites this paper
• Osteocytes

  2021cites this paper
• The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies

  2021influential citation
• Update on the effects of microgravity on the musculoskeletal system

  2021cites this paper
• Parathyroid Hormones

  2020cites this paper
• The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases

  2020cites this paper
• Skeletal tissue regulation by catalase over-expression in mitochondria.

  2020cites this paper
• Re-thinking the bone remodeling cycle mechanism and the origin of bone loss.

  2020influential citation
• Estrogens and progestins

  2020cites this paper
• Bone turnover markers

  2020cites this paper
• Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis

  2020cites this paper
• A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction

  2020cites this paper
• PERK controls bone homeostasis through the regulation of osteoclast differentiation and function

  2020cites this paper
• Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications

  2020cites this paper
• A butanolic fraction from the standardized stem extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophy

  2020cites this paper
• IL-33/IL-31 Axis in Osteoporosis

  2020cites this paper
• Effect of fluoride on osteocyte-driven osteoclastic differentiation.

  2020cites this paper
• Apoptotic Osteocytes Induce RANKL Production in Bystanders via Purinergic Signaling and Activation of Pannexin Channels

  2020cites this paper
• Elevation of the unfolded protein response increases RANKL expression

  2020cites this paper
• Skeletal stem cells

  2020cites this paper
• Periodontal ligament cells in adolescents and adults: Genetic level responses to orthodontic forces.

  2020cites this paper
• The molecular actions of parathyroid hormone/parathyroid hormone–related protein receptor type 1 and their implications

  2020cites this paper
• Les inhibiteurs de la voie Wnt dans un modèle animal d'insuffisance rénale chronique avec calcification vasculaire

  2020cites this paper
• Computational model of the dual action of PTH - Application to a rat model of osteoporosis.

  2019cites this paper
• A Review of Dysregulated Osteoblast and Osteoclast Coupling in Bone Disease and Failure

  2019cites this paper
• The osteocyte: a multifunctional cell within the bone.

  2019cites this paper
• INTERLEUKIN 1-BETA (IL-1Β) POLYMORPHISM AND ORTHODONTICS: A SYSTEMATIC REVIEW

  2019cites this paper
• Journal of Bone and Mineral Research

  2019cites this paper
• Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties

  2019cites this paper
• Vitamin D – new insights into an old molecule

  2019cites this paper
• Irradiation‐induced osteocyte damage promotes HMGB1‐mediated osteoclastogenesis in vitro

  2019cites this paper
• Mechanical loading induced osteocyte apoptosis and connexin 43 expression in three-dimensional cell culture and dental implant model.

  2019cites this paper
• Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction

  2019cites this paper